Ladenburg Thalmann Financial Services’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$147K Sell
3,900
-1,982
-34% -$89.1K ﹤0.01% 2737
2019
Q3
$274K Buy
5,882
+285
+5% +$13.3K ﹤0.01% 2234
2019
Q2
$292K Buy
5,597
+516
+10% +$30.3K ﹤0.01% 2165
2019
Q1
$350K Buy
5,081
+2,615
+106% +$175K ﹤0.01% 1963
2018
Q4
$148K Buy
2,466
+318
+15% +$27.4K ﹤0.01% 2461
2018
Q3
$249K Sell
2,148
-298
-12% -$33.6K ﹤0.01% 2140
2018
Q2
$264K Hold
2,446
﹤0.01% 2015
2018
Q1
$264K Sell
2,446
-1,704
-41% -$189K ﹤0.01% 2015
2017
Q4
$456K Buy
4,150
+499
+14% +$49.8K ﹤0.01% 1619
2017
Q3
$360K Sell
3,651
-1,346
-27% -$130K ﹤0.01% 1671
2017
Q2
$506K Buy
4,997
+223
+5% +$24K 0.01% 1383
2017
Q1
$552K Sell
4,774
-20
-0.4% -$2.32K 0.01% 1268
2016
Q4
$576K Buy
4,794
+2,295
+92% +$254K 0.01% 1173
2016
Q3
$281K Buy
2,499
+209
+9% +$24.1K ﹤0.01% 1524
2016
Q2
$284K Sell
2,290
-114
-5% -$13.8K ﹤0.01% 1452
2016
Q1
$269K Sell
2,404
-68
-3% -$7.07K ﹤0.01% 1408
2015
Q4
$269K Sell
2,472
-1,622
-40% -$186K 0.01% 1379
2015
Q3
$408K Buy
4,094
+114
+3% +$12.4K 0.01% 1079
2015
Q2
$454K Buy
3,980
+177
+5% +$21.5K 0.01% 1094
2015
Q1
$397K Buy
3,803
+1,153
+44% +$123K 0.01% 1157
2014
Q4
$317K Sell
2,650
-7,892
-75% -$1.04M 0.01% 1157
2014
Q3
$1.54M Buy
10,542
+8,604
+444% +$1.33M 0.04% 362
2014
Q2
$324K Sell
1,938
-1,183
-38% -$210K 0.01% 961
2014
Q1
$619K Buy
3,121
+157
+5% +$29.6K 0.02% 644
2013
Q4
$564K Buy
2,964
+1,778
+150% +$331K 0.02% 653
2013
Q3
$205K Buy
1,186
+53
+5% +$8.23K 0.01% 1003
2013
Q2
$172K Buy
+1,133
New +$161K 0.01% 1046

Other funds holding CLB

Ladenburg Thalmann Financial Services's CLB Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Core Laboratories (CLB) stake by 34% in Q4 2019, selling an estimated $89.1K and leaving 3,900 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #2737.

Ladenburg Thalmann Financial Services first reported a position in CLB in Q2 2013 and has held it in 27 quarters since. The position peaked at $1.54M in Q3 2014. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 3,900 shares of Core Laboratories worth $147K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 1,982 Core Laboratories shares in Q4 2019, an estimated $89.1K.
  • Core Laboratories made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2737 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Core Laboratories in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Core Laboratories position peaked at $1.54M in Q3 2014.
  • 283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.